title: DOCUMENT: a system for classifying drug-related problems in community pharmacy.
abstract: BACKGROUND
  Drug-related problems (DRPs) are a major burden on the Australian healthcare system. Community pharmacists are in an ideal position to detect, prevent, and resolve these DRPs. Objective To develop and validate an easy-to-use documentation system for pharmacists to classify and record DRPs, and to investigate the nature and frequency of clinical interventions undertaken by Australian community pharmacists to prevent or resolve them. Setting Australian community pharmacies.
  
  
  METHODS
  The DOCUMENT classification system was developed, validated and refined during two pilot studies. The system was then incorporated into software installed in 185 Australian pharmacies to record DRPs and clinical interventions undertaken by pharmacists during a 12-week trial.
  
  
  METHODS
  The number and nature of DRPs detected within Australian community pharmacies.
  
  
  RESULTS
  A total of 5,948 DRPs and clinical interventions were documented from 2,013,923 prescriptions dispensed during the trial (intervention frequency 0.3%). Interventions were commonly related to Drug selection problems (30.7%) or Educational issues (23.7%). Pharmacists made an average of 1.6 recommendations per intervention, commonly relating to A change in therapy (40.1%) and Provision of information (34.7%). Almost half of interventions (42.6%) were classified by recording pharmacists as being at a higher level of clinical significance.
  
  
  CONCLUSIONS
  The DOCUMENT system provided pharmacists with a useful and easy-to-use tool for recording DRPs and clinical interventions. Results from the trial have provided a better understanding of the frequency and nature of clinical interventions performed in Australian community pharmacies, and lead to a national implementation of the system.
authors.affiliation: School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, TAS, 7001, Australia. Mackenzie.Williams@utas.edu.au
authors.forename: Mackenzie
authors.initials: M
authors.lastname: Williams
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Peterson
authors.forename: Peter C
authors.initials: PC
authors.lastname: Tenni
authors.forename: Ivan K
authors.initials: IK
authors.lastname: Bindoff
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Stafford
mesh_terms: D001315:Australia; D016303:Clinical Pharmacy Information Systems; D003157:Community Pharmacy Services / Q000458:organization & administration*; D004282:Documentation; D006801:Humans; D010595:Pharmacists / Q000458:organization & administration*; D010865:Pilot Projects; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D055553:Prescription Drugs / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D055553:Prescription Drugs
references.citation: J R Soc Med. 2010 Jun;103(6):239-50
references.pmid: 20513902
references.citation: N Engl J Med. 2003 Apr 17;348(16):1556-64
references.pmid: 12700376
references.citation: Ann Pharmacother. 2006 Jun;40(6):1162-9
references.pmid: 16735653
references.citation: Pharm World Sci. 2008 Dec;30(6):777-86
references.pmid: 18392732
references.citation: Ann Pharmacother. 2011 Jul;45(7-8):977-89
references.pmid: 21693697
references.citation: Pharm World Sci. 2008 Dec;30(6):768-76
references.pmid: 18357512
references.citation: Am J Hosp Pharm. 1990 Mar;47(3):533-43
references.pmid: 2316538
references.citation: Pharm World Sci. 2010 Jun;32(3):362-72
references.pmid: 20229029
references.citation: Pharm World Sci. 2002 Aug;24(4):120-7
references.pmid: 12227243
references.citation: Br J Clin Pharmacol. 2007 Feb;63(2):136-47
references.pmid: 16803468
references.citation: Drugs Aging. 2011 Apr 1;28(4):305-14
references.pmid: 21428465
references.citation: Pharm World Sci. 2010 Jun;32(3):394-403
references.pmid: 20407926
references.citation: Ann Pharmacother. 2002 Jul-Aug;36(7-8):1238-48
references.pmid: 12086559
references.citation: Aust New Zealand Health Policy. 2009 Aug 11;6:18
references.pmid: 19671158
references.citation: Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):901-10
references.pmid: 20623513
references.citation: Pharm World Sci. 2003 Apr;25(2):65-9
references.pmid: 12774566
references.citation: Curr Pharm Des. 2004;10(31):3931-46
references.pmid: 15579081